Most Americans believe there is a connection between oral and overall health, according to the CareQuest Institute for Oral Health's "State of Oral Health Equity in America" survey.
Clinical Leadership
From the effects of nanozyme therapy on dental plaque to the link between oral bacteria and hypertension, here are five recent dental studies to know:
The ADA offered guidance on how the No Surprises Act could affect dental practices and six other federal government and policy updates for dentists to know from the last month:
The American Dental Association offered guidance on how the recently enacted No Surprises Act could affect dental practices.
The Partnership for Medicaid recently called on Congress to give state Medicaid agencies 120 days to prepare for the conclusion of the Families First Coronavirus Response Act.
ADA researchers recently collaborated with the National Institute of Standards and Technology on a study that could lead to more information on how experimental gum disease drugs affect blood vessels.
Patients given alternative antibiotics to amoxicillin are more than twice as likely to experience dental implant failure compared to those given amoxicillin, according to a study by researchers at NYU College of Dentistry in New York City.
The Ensuring Lasting Smiles Act, a legislation requiring insurers to cover dental and oral procedures to treat birth defects, passed the House of Representatives April 4.
At the fourth Conference of the Parties to the Minamata Convention on Mercury, more than 130 nations unanimously agreed to an amendment requiring countries to protect vulnerable populations from dental amalgam use.
The National Commission on Recognition of Dental Specialties and Certifying Boards on March 28 recognized the American Board of Orofacial Pain as the national certifying board for orofacial pain specialists.